Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: Cardio, Antibiotic Approvals Put FDA Over Last Year's Novel Drug Count

26 Jun 2017

• By Michael Cipriano

Related Content

Pfizer’s EPO Biosimilar Stalls In US On Hospira Compliance Woes

22 Jun 2017

Keeping Track: Teva's Austedo Clears US FDA, Merck Sitagliptin CV Outcomes Labeling Draws Complete Response

07 Apr 2017

Biosimilar Advisory Committees Getting Smoother, Even As Worries Stay The Same

25 May 2017

Pfizer Suffered 'Significant Loss Of Control' At McPherson Plant, US FDA Warning Letter Says

01 Mar 2017

Pfizer Will Study Oxecta Abuse/Misuse Potential Post-Market

20 Jun 2011

Genentech's Subcutaneous Rituximab Breezes Through US FDA Advisory Committee

30 Mar 2017

Subcutaneous Rituximab Seems Headed For US FDA Advisory Panel OK

28 Mar 2017

Melinta To Launch First Commercial Drug Baxdela Independently

22 Jun 2017

Shire CEO: Mydayis To Be Big ADHD Drug, But No Ex-US Launch Planned (Yet)

21 Jun 2017

Cara Resuming Phase III Trial In Post-Op Pain After Clinical Hold Lifts

20 Apr 2016

Keeping Track: Immuno-Oncologics And Abuse-Deterrent Opioids Take Center Stage (Again); Jardiance CV Claim Approved

04 Dec 2016

Biosimilar Denied: Hospira's Retacrit Could Head Back To FDA In First Half 2016

28 Oct 2015

Neos' ADHD Drug Won't Launch Until 2017 As FDA Requires Clinical-Commercial Bridging Study

11 Nov 2015

Keeping Track: Merck's Winning Week; Novel Agents Submitted By GSK, Melinta, Portola

30 Oct 2016

Keeping Track: FDA Approves First Rx DHEA, Receives Applications For Midostaurin, Gesulkumab, Biosimilar Avastin

21 Nov 2016

When Is An Abuse-Deterrent Claim FDA Approved?

20 Jun 2016

Related Companies

Portola Pharmaceuticals, Inc.

Novartis AG

Genentech, Inc.

Neos Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Pfizer Inc.

Hospira, Inc.

Zyla Life Sciences

Melinta Therapeutics, Inc.

CSL Limited

Thermo Fisher Scientific

GSK plc

Roche Holding AG

Halozyme Therapeutics, Inc.

Neos Therapeutics, Inc.

Zyla Life Sciences

Acura Pharmaceuticals, Inc.

Amgen, Inc.

Johnson & Johnson

Cara Therapeutics, Inc.

Rigel Pharmaceuticals, Inc.

Amgen, Inc.

Additional Topics

United States Regulation Approvals BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.